[US, FDA] Webinar – FDA’s Total Product Life Cycle Approach to In Vitro Diagnostic Products (IVDs)

Summary

On October 24, 2024, the U.S. Food and Drug Administration (FDA) will host a webinar for laboratory manufacturers and other interested parties to discuss the FDA’s Total Product Life Cycle (TPLC) approach to the oversight of in vitro diagnostic products (IVDs). 

The FDA’s TPLC approach allows the FDA to review and monitor medical devices throughout their life cycle by taking into account all available information on safety and effectiveness. 

 

 

Webinar – FDA’s Total Product Life Cycle Approach to In Vitro Diagnostic Products (IVDs) - 10/24/2024 | FDA

TPLC approach to in vitro diagnostic products (IVDs)

---